FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: AMENDING OVER-THE-COUNTER MONOGRAPH M020: SUNSCREEN DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE, AND RELATED INFORMATION; AMINOBENZOIC ACID (PABA) AND TROLAMINE SALICYLATE

WASHINGTON, Sept. 11 -- Food and Drug Administration has issued a notice called: Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related Information; Aminobenzoic Acid (PABA) and Trolamine Salicylate.

The notice was published in the Federal Register on Sept. 11 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA or Agency) is announcing the availability on its website of the final administrative order (final order) (OTC000008-1) titled "Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related Information; Aminobenzoic Acid (PABA) and Trolamine Sali...